Shayan Mohammadmoradi: Why Cardiovascular Research in Kentucky Is More Than Just Publishing Papers
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared on LinkedIn:
“In my recent op-ed, I reflect on why doing this work here in Kentucky carries urgency and responsibility.
Every discovery has the potential to directly impact the people around us.
At the University of Kentucky College of Medicine, we are uniquely positioned at the forefront of cardiovascular research.
Through centers like the Cardiovascular Research Center and the Barnstable Brown Diabetes and Obesity Center, and Gill Heart and Vascular Institur UK integrates basic science, translational research, and clinical care under one roof.
That proximity, lab to clinic to community, accelerates impact in ways few institutions can.
As a scientist and volunteer leader with American Heart Association, I also see how national advocacy, research funding, and community engagement amplify what we do locally.
Science, policy, and prevention must move together.
Cardiovascular research in Kentucky is not just about publishing papers.
It is about responsibility.
It is about regional leadership.
It is about changing outcomes where the need is greatest.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies
-
Sep 30, 2026, 12:52Paul Watton: Could Repetitive Head Impacts Leave a Molecular Memory?
-
Sep 30, 2026, 12:41The Journey to ISTH 2027 Starts in Vancouver
-
Sep 30, 2026, 11:36Basit Ali: A Closer Look at CT Venography
-
Sep 30, 2026, 11:16Christina Pohlman: Could aPL Levels Help Predict Stroke Recurrence?